Widely used blood pressure medication recalled nationwide
Key Points:
- Inventia Healthcare Ltd. has voluntarily recalled 13,567 bottles of 25-milligram chlorthalidone tablets nationwide due to failure in dissolution quality testing, as reported by the FDA.
- Chlorthalidone, used to treat high blood pressure and fluid retention, was recalled in bottles containing 100 pills each with an expiration date of April 2027.
- The FDA classified the recall as Class II, indicating the product may cause temporary or medically reversible adverse health effects, with a low probability of serious consequences.
- This is the second recall of this product in 2023, with a previous recall in June affecting over 11,400 bottles for similar dissolution issues.
- Inventia Healthcare has not yet provided a comment on the recall following inquiries from FOX Business.